End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
118.4 BDT | -0.50% | +1.98% | -19.02% |
Sales 2024 * | 44.55B 409M | Sales 2025 * | 50.49B 464M | Capitalization | 52.82B 485M |
---|---|---|---|---|---|
Net income 2024 * | 5.13B 47.14M | Net income 2025 * | 6B 55.12M | EV / Sales 2024 * | 1.32 x |
Net Debt 2024 * | 5.99B 55.05M | Net Debt 2025 * | 884M 8.12M | EV / Sales 2025 * | 1.06 x |
P/E ratio 2024 * |
9.63
x | P/E ratio 2025 * |
7.84
x | Employees | 5,700 |
Yield 2024 * |
3.38% | Yield 2025 * |
4.22% | Free-Float | 76.68% |
1 day | -0.50% | ||
1 week | +1.98% | ||
Current month | -0.50% | ||
1 month | +1.11% | ||
3 months | -10.30% | ||
6 months | -19.02% | ||
Current year | -19.02% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 61 | 89-12-31 | |
Chief Tech/Sci/R&D Officer | - | - | |
Selina Akter
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 75-12-31 | |
Founder | - | 75-12-31 | |
Iqbal Ahmed
CEO | Chief Executive Officer | - | 84-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 118.4 | -0.50% | 105,753 |
24-04-30 | 119 | +2.06% | 123,704 |
24-04-29 | 116.6 | -2.59% | 74,645 |
24-04-28 | 119.7 | +3.10% | 108,792 |
End-of-day quote Dhaka S.E., May 01, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.02% | 482M | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- BXPHARMA Stock